Tokyo Tape
Sign in
← Mitsubishi Chemical Group

Half-year report · Q2

4188.TEDINET S100UP7B
Period2024-04-01 → 2024-09-30
Filed2024-11-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥2.24T2024-04-01 → 2024-09-30Cons.Revenue IFRS
Revenue¥4.39T2023-04-01 → 2024-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥2.15T2023-04-01 → 2023-09-30Cons.Revenue IFRS
Operating income¥136.7bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Operating income¥138.6bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Profit before tax¥106.1bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Profit before tax¥240.5bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥130.2bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥40.9bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥119.6bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥67.2bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥71.2bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Net income¥178.4bn2023-04-01 → 2024-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥94.1bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Total assets¥5.95Tat 2024-09-30Cons.Assets IFRS
Total assets¥6.10Tat 2024-03-31Cons.Assets IFRS
Total assets¥6.12Tat 2023-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥3.69Tat 2024-09-30Cons.Liabilities IFRS
Total liabilities¥3.83Tat 2024-03-31Cons.Liabilities IFRS
Net assets / equity¥2.26Tat 2024-09-30Cons.Equity IFRS
Net assets / equity¥2.28Tat 2024-03-31Cons.Equity IFRS
Net assets / equity¥2.21Tat 2023-09-30Cons.Equity IFRS
Net assets / equity¥1.99Tat 2023-03-31dCons.Equity IFRS
Equity (owners)¥1.74Tat 2024-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.76Tat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.72Tat 2023-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥297.5bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥294.9bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥398.8bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥297.2bnat 2023-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥275.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥465.1bn2023-04-01 → 2024-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥195.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥145.3bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥246.1bn2023-04-01 → 2024-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥115.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥124.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥241.7bn2023-04-01 → 2024-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥6.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥28.762024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥84.072023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥47.252023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥28.742024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥80.772023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥45.222023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio29.2%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.9%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.2%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥149.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥78.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-04-01 → 2024-09-30¥70.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥4.3bn
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥106.6bn
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥106.6bn
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥5.1bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue2024-04-01 → 2024-09-30¥539.3bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue external2024-04-01 → 2024-09-30¥521.1bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥18.2bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentsegment profit2024-04-01 → 2024-09-30−¥10.5bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue2024-04-01 → 2024-09-30¥643.0bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue external2024-04-01 → 2024-09-30¥639.4bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥3.6bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentsegment profit2024-04-01 → 2024-09-30¥91.9bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue2024-04-01 → 2024-09-30¥235.9bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue external2024-04-01 → 2024-09-30¥227.4bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥8.5bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentsegment profit2024-04-01 → 2024-09-30¥25.9bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue2024-04-01 → 2024-09-30¥232.6bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue external2024-04-01 → 2024-09-30¥232.5bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥50m
jpcrp040300-q2r_E00808-000Pharmareportable segmentsegment profit2024-04-01 → 2024-09-30¥41.4bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue2024-04-01 → 2024-09-30¥548.1bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue external2024-04-01 → 2024-09-30¥542.7bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥5.4bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentsegment profit2024-04-01 → 2024-09-30¥24.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥165.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥92.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-09-30¥73.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30¥6.1bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥108.8bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥108.8bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥5.5bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue2023-04-01 → 2023-09-30¥548.3bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue external2023-04-01 → 2023-09-30¥528.7bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥19.6bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentsegment profit2023-04-01 → 2023-09-30−¥14.6bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue2023-04-01 → 2023-09-30¥612.6bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue external2023-04-01 → 2023-09-30¥608.2bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥4.3bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentsegment profit2023-04-01 → 2023-09-30¥80.3bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue2023-04-01 → 2023-09-30¥187.4bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue external2023-04-01 → 2023-09-30¥181.2bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥6.1bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentsegment profit2023-04-01 → 2023-09-30¥2.2bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue2023-04-01 → 2023-09-30¥219.4bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue external2023-04-01 → 2023-09-30¥219.3bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥67m
jpcrp040300-q2r_E00808-000Pharmareportable segmentsegment profit2023-04-01 → 2023-09-30¥32.3bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue2023-04-01 → 2023-09-30¥525.7bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue external2023-04-01 → 2023-09-30¥520.2bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥5.5bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentsegment profit2023-04-01 → 2023-09-30¥18.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 887
ItemContextValueUnit
Redemption of bonds fin cf IFRSCurrentYTDDuration-15000000000JPY
Repayments of lease obligations fin cf IFRSPrior1YTDDuration-17420000000JPY
Repayments of lease obligations fin cf IFRSCurrentYTDDuration-17127000000JPY
Net decrease increase in treasury shares fin cf IFRSPrior1YTDDuration-13000000JPY
Net decrease increase in treasury shares fin cf IFRSCurrentYTDDuration-15000000JPY
Dividends paid fin cf IFRSPrior1YTDDuration-21333000000JPY
Dividends paid fin cf IFRSCurrentYTDDuration-22762000000JPY
Dividends paid to non controlling interests fin cf IFRSPrior1YTDDuration-7495000000JPY
Dividends paid to non controlling interests fin cf IFRSCurrentYTDDuration-8446000000JPY
Other fin cf IFRSPrior1YTDDuration-116000000JPY
Other fin cf IFRSCurrentYTDDuration-36000000JPY
Net cash provided by used in financing activities IFRSPrior1YTDDuration6512000000JPY
Net cash provided by used in financing activities IFRSCurrentYTDDuration-124004000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1YTDDuration18392000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSCurrentYTDDuration-4573000000JPY
Net increase decrease in cash and cash equivalents IFRSPrior1YTDDuration104984000000JPY
Net increase decrease in cash and cash equivalents IFRSCurrentYTDDuration1205000000JPY
Cash and cash equivalents IFRSPrior2YearInstant297224000000JPY
Cash and cash equivalents IFRSPrior1YearInstant294924000000JPY
Net increase decrease in cash and cash equivalents resulting from transfer to assets held for sale IFRSPrior1YTDDuration-3376000000JPY
Net increase decrease in cash and cash equivalents resulting from transfer to assets held for sale IFRSCurrentYTDDuration1397000000JPY
Cash and cash equivalents IFRSPrior1QuarterInstant398832000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant297526000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000SpecialtyMaterialsReportableSegmentMember520166000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000IndustrialGasesReportableSegmentMember608236000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000PharmaReportableSegmentMember219331000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000MMAAndDerivativesReportableSegmentMember181240000000JPY
Revenue from external customers IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000BasicMaterialsAndPolymersReportableSegmentMember528745000000JPY
Revenue from external customers IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember92180000000JPY
Revenue from external customers IFRSPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenue from external customers IFRSPrior1YTDDuration2149898000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000SpecialtyMaterialsReportableSegmentMember5491000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000IndustrialGasesReportableSegmentMember4336000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000PharmaReportableSegmentMember67000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000MMAAndDerivativesReportableSegmentMember6141000000JPY
Intersegment revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000BasicMaterialsAndPolymersReportableSegmentMember19560000000JPY
Intersegment revenue IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember73222000000JPY
Intersegment revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-108817000000JPY
Intersegment revenue IFRSPrior1YTDDuration－JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000SpecialtyMaterialsReportableSegmentMember525657000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000IndustrialGasesReportableSegmentMember612572000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000PharmaReportableSegmentMember219398000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000MMAAndDerivativesReportableSegmentMember187381000000JPY
Revenue IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000BasicMaterialsAndPolymersReportableSegmentMember548305000000JPY
Revenue IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember165402000000JPY
Revenue IFRSPrior1YTDDuration_ReconcilingItemsMember-108817000000JPY
Revenue IFRSPrior1YTDDuration2149898000000JPY
Segment profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000SpecialtyMaterialsReportableSegmentMember18812000000JPY
Segment profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000IndustrialGasesReportableSegmentMember80271000000JPY
Segment profit loss IFRSPrior1YTDDuration_jpcrp040300-q2r_E00808-000PharmaReportableSegmentMember32334000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass